-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2019 to Q3 2024.
- InMed Pharmaceuticals Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $41K, unchanged year-over-year.
- InMed Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2024 was $172K, a 7.93% increase from 2023.
- InMed Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2023 was $159K, unchanged from 2022.
- InMed Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2022 was $159K, a 59.7% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)